Axogen, Inc. (AXGN) Operating Margin
- Operating margin · 12 months: Value -5.12%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -5.12% | Operating income / revenue. Period ending 2026-06-30. $-12.85M ÷ $251.17M × 100 ≈ -5.12% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -12.85M USD | Operating Income (Loss) |
| Revenue | 251.17M USD | |
| Cost of products and services | 63.91M USD | Cost of Goods and Services Sold |
| Research and development | 36.05M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-12.85M | $251.17M | $63.91M | $36.05M | (m) | -5.12% |
| 2026-03-31 | $-9.02M | $238.10M | $59.50M | $34.31M | (m) | -3.79% |
| 2025-12-31 | $-7.85M | $225.21M | $57.85M | $32.88M | (m) | -3.49% |
| 2025-09-30 | $3.94M | $214.71M | $54.19M | $27.21M | (m) | 1.84% |
| 2025-06-30 | $1.71M | $203.27M | $52.31M | $26.64M | (m) | 0.84% |
| 2025-03-31 | $-388.00K | $194.52M | $50.23M | $26.45M | (m) | -0.20% |
| 2024-12-31 | $-3.29M | $187.34M | $45.36M | $27.77M | (m) | -1.75% |
| 2024-09-30 | $-8.50M | $180.85M | $38.43M | $29.23M | (m) | -4.70% |
| 2024-06-30 | $-12.21M | $173.48M | $35.79M | $28.93M | (m) | -7.04% |
| 2024-03-31 | $-18.68M | $163.73M | $31.72M | $29.42M | (m) | -11.41% |
| 2023-12-31 | $-21.46M | $159.01M | $31.14M | $28.33M | (m) | -13.50% |
| 2023-09-30 | $-23.88M | $152.25M | $28.12M | $27.84M | (m) | -15.68% |
| 2023-06-30 | $-24.71M | $147.94M | $26.25M | $27.91M | (m) | -16.70% |
| 2023-03-31 | $-25.73M | $144.24M | $25.31M | $27.56M | (m) | -17.84% |
| 2022-12-31 | $-29.71M | $138.58M | $24.15M | $27.16M | (m) | -21.44% |
| 2022-09-30 | $-29.45M | $133.96M | $23.43M | $26.65M | (m) | -21.99% |
| 2022-06-30 | $-31.29M | $128.20M | $22.50M | $26.00M | (m) | -24.40% |
| 2022-03-31 | $-30.52M | $127.33M | $23.30M | $24.70M | (m) | -23.97% |
| 2021-12-31 | $-25.42M | $127.36M | $22.93M | $24.18M | (m) | -19.96% |
| 2021-09-30 | $-25.44M | $128.32M | $22.97M | $22.81M | (m) | -19.82% |
| 2021-06-30 | $-19.79M | $130.54M | $23.42M | $20.63M | (m) | -15.16% |
| 2021-03-31 | $-20.89M | $119.08M | $21.94M | $18.98M | (m) | -17.55% |
| 2020-12-31 | $-23.18M | $112.30M | $21.58M | $17.85M | (m) | -20.64% |
| 2020-09-30 | $-25.23M | $107.97M | $21.00M | $17.83M | (m) | -23.37% |
| 2020-06-30 | $-30.29M | $103.10M | $19.81M | $17.78M | (m) | -29.38% |
| 2020-03-31 | $-29.71M | $107.69M | $18.45M | $17.99M | (m) | -27.59% |
| 2019-12-31 | $-31.41M | $106.71M | $17.35M | $17.51M | (m) | -29.43% |
| 2019-09-30 | $-29.84M | $101.98M | $16.11M | $16.41M | (m) | -29.26% |
| 2019-06-30 | $-28.57M | $96.08M | $15.06M | $15.53M | (m) | -29.73% |
| 2019-03-31 | $-25.71M | $89.96M | $13.93M | $13.85M | (m) | -28.58% |
| 2018-12-31 | $-20.50M | $83.94M | $12.92M | $11.77M | (m) | -24.42% |
| 2018-09-30 | $-16.45M | $77.48M | (m) | $9.94M | (m) | -21.23% |
| 2018-06-30 | $-13.12M | $70.86M | (m) | $8.43M | (m) | -18.51% |
| 2018-03-31 | $-9.74M | $65.45M | (m) | $7.35M | (m) | -14.89% |
| 2017-12-31 | $-7.95M | $60.43M | (m) | $6.70M | (m) | -13.16% |
| 2017-09-30 | $-8.86M | $54.86M | (m) | $5.91M | (m) | -16.16% |
| 2017-06-30 | $-8.55M | $50.02M | (m) | $5.23M | (m) | -17.09% |
| 2017-03-31 | $-8.71M | $45.24M | (m) | $4.64M | (m) | -19.25% |
| 2016-12-31 | $-8.13M | $41.11M | (m) | $4.21M | (m) | -19.78% |
| 2016-09-30 | $-8.06M | $37.51M | (m) | $3.93M | (m) | -21.50% |
| 2016-06-30 | $-8.80M | $34.46M | (m) | $3.74M | (m) | -25.54% |
| 2016-03-31 | $-9.35M | $30.49M | (m) | $3.54M | (m) | -30.65% |
| 2015-12-31 | $-9.27M | $27.33M | (m) | $3.24M | (m) | -33.91% |
| 2015-09-30 | $-9.32M | $24.32M | (m) | $3.33M | (m) | -38.34% |
| 2015-06-30 | $-9.21M | $20.83M | (m) | $3.07M | (m) | -44.20% |
| 2015-03-31 | $-9.35M | $18.63M | (m) | $2.89M | (m) | -50.20% |
| 2014-12-31 | $-9.80M | $16.82M | (m) | $3.03M | (m) | -58.28% |
| 2014-09-30 | $-9.89M | $15.01M | (m) | $2.68M | (m) | -65.89% |
| 2014-06-30 | $-10.36M | $13.29M | (m) | $2.59M | (m) | -77.95% |
| 2014-03-31 | $-10.26M | $11.94M | (m) | $2.53M | (m) | -85.91% |
| 2013-12-31 | $-9.59M | $10.95M | (m) | $2.13M | (m) | -87.62% |
| 2013-09-30 | $-9.03M | $10.01M | (m) | $1.87M | (m) | -90.19% |
| 2013-06-30 | $-8.79M | $9.03M | (m) | $1.67M | (m) | -97.35% |
| 2013-03-31 | $-8.18M | $8.18M | (m) | $1.54M | (m) | -100.04% |
| 2012-12-31 | $-7.80M | $7.69M | (m) | $1.43M | (m) | -101.43% |
| 2012-09-30 | $-7.56M | $7.01M | (m) | $1.31M | (m) | -107.87% |
| 2012-06-30 | $-8.14M | $6.17M | (m) | $1.15M | (m) | -132.02% |
| 2012-03-31 | $-8.01M | $5.38M | (m) | $887.89K | (m) | -148.81% |
| 2011-12-31 | $-6.97M | $4.85M | (m) | $697.36K | (m) | -143.70% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-4.48M | $3.00M | (m) | $436.01K | (m) | -149.16% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |